Drug Profile
Research programme: sodium glucose co-transporter inhibitors - Taisho
Alternative Names: SGLT inhibitors - TaishoLatest Information Update: 23 Sep 2011
Price :
$50
*
At a glance
- Originator Taisho Pharmaceutical
- Class Small molecules
- Mechanism of Action Sodium-glucose transport protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 25 Jul 2007 Preclinical development is ongoing
- 01 Nov 2005 Data presented at the 41st Annual Meeting of the European Association for the Study of Diabetes (EASD-2005) has been added to the Diabetes pharmacodynamics section
- 06 Jul 2005 Preclinical trials in Type-2 diabetes mellitus in Japan (unspecified route)